Hanchao Cheng

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0003-4551-4614

发表论文 17 篇 · 总被引 122 次 · h-index 6

代表论文

• What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review (2021 · The Lancet Regional Health - Western Pacific · 被引 29)
• Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China (2022 · Infectious Diseases and Therapy · 被引 25)
• Impact of zero-mark-up medicines policy on hospital revenue structure: a panel data analysis of 136 public tertiary hospitals in China, 2012–2020 (2021 · BMJ Global Health · 被引 19)
• Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021 (2023 · Infectious Diseases of Poverty · 被引 17)
• Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China (2023 · Frontiers in Pharmacology · 被引 7)
• The burden of acute respiratory infection in children under 5 attributable to economic inequality in low- and middle-income countries (2025 · BMJ Global Health · 被引 6)